Now that the Supreme Court has announced it will rule Thursday on President Barack Obama's 2010 health-care overhaul, one of the biggest questions that hangs over the decision is what happens to the billions of dollars already spent or pledged to carry out the law if parts or all of it are struck down.
Read the full story: http://tinyurl.com/872dv8p
Source: The Wall Street Journal
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More